Published in Medical Letter on the CDC and FDA, January 8th, 2006
The supplemental application is based on data from a phase III international study, TAX 325, involving 457 patients with advanced gastric cancer. Patients treated with a Taxotere-based chemotherapy regimen (Taxotere, cisplatin, and 5-fluorouracil) had a significantly improved overall survival compared to patients who received a standard treatment of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA